Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.
Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.
复制标题
DOI:
10.1136/jim-2018-000786
复制
发表时间:
2018-12
期刊:
影响因子:
--
通讯作者:
Siddiqui AA
中科院分区:
文献类型:
--
作者:
Zhang W;Ahmad G;Molehin AJ;Torben W;Le L;Kim E;Lazarus S;Siddiqui AJ;Carter D;Siddiqui AA
Sm-p80, the large subunit of Schistosoma mansoni calpain, is a leading candidate for a schistosomiasis vaccine. The prophylactic and antifecundity efficacy of Sm-p80 has been tested in three animal models (mouse, hamster and baboon) using a multitude of vaccine formulations and approaches. In our continual effort to enhance the vaccine efficacy, in this study, we have utilized the adjuvant, synthetic hexa-acylated lipid A derivative, glucopyranosyl lipid A (GLA) formulated in aluminum (GLA-Alum) with recombinant Sm-p80. The rSm-p80+GLA-Alum immunization regimen provided 33.33%–53.13% reduction in worm burden in the mouse model and 38% worm burden reduction in vaccinated baboons. Robust Sm-p80-specific immunoglobulin (Ig)G, IgG1, IgG2a and IgM responses were observed in all immunized animals. The rSm-p80+GLA-Alum coadministration induced a mix of T-helper (Th) cells (Th1, Th2 and Th17) responses as determined via the release of interleukin (IL)-2, IL-4, IL-18, IL-21, IL-22 and interferon-γ.
登录
查看更多内容
影响因子:
2
作者:
Molehin AJ;Sennoune SR;Zhang W;Rojo JU;Siddiqui AJ;Herrera KA;Johnson L;Sudduth J;May J;Siddiqui AA
通讯作者:
Siddiqui AA
影响因子:
3.8
作者:
Li XH;Xu YX;Vance G;Wang Y;Lv LB;van Dam GJ;Cao JP;Wilson RA
通讯作者:
Wilson RA
影响因子:
3.7
作者:
Ricciardi A;Visitsunthorn K;Dalton JP;Ndao M
通讯作者:
Ndao M
影响因子:
6.4
作者:
Karmakar, Souvik;Zhang, Weidong;Siddiqui, Afzal A.
通讯作者:
Siddiqui, Afzal A.
影响因子:
5.5
作者:
Ahmad G;Zhang W;Torben W;Damian RT;Wolf RF;White GL;Chavez-Suarez M;Kennedy RC;Siddiqui AA
通讯作者:
Siddiqui AA